Moleculin Biotech, Inc.MBRX
Moleculin Biotech, Inc., a healthcare name on Nasdaq.
Moleculin Biotech, Inc., ticker MBRX, is a healthcare company listed on Nasdaq operating in pharmaceutical preparations.
A descriptive overview for MBRX is pending the next reference-data sync.
MBRX on the desk: alerts, trims, and member tracking.
Below is the outcome history for MBRX from Stock Sensei's alert feed. Entry, target, and stop levels, plus the chart-level reasoning, are members-only.
- BUYFeb 14, 2025Hit+26.94%
- BUYFeb 14, 2025Hit+31.13%
Full details unlock inside the app
Common questions about this stock.
What is MBRX?
MBRX is the trading symbol for Moleculin Biotech, Inc., listed on Nasdaq in the healthcare sector.
What sector is MBRX in?
Moleculin Biotech, Inc. (MBRX) is classified in the healthcare sector, specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Stock Sensei traded MBRX?
Yes, MBRX has appeared in the Stock Sensei alert feed 2 times, including 2 calls that hit target. The "Stock Sensei's calls on MBRX" section above lists the recent history; entry, target, and stop levels are members-only.
Where does MBRX trade?
MBRX trades on Nasdaq.
Is MBRX a stock or an ETF?
MBRX is a publicly-traded common stock, not an ETF.
Trade MBRX alongside Stock Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.